Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapidpath to bring to market drugs and vaccines that are formulated into a proprietary patchtechnology that simplifies and improves the way actives are delivered, stored, and distributed.This technology is designed to increase patient access to drugs and vaccines that wouldotherwise require expert injection and to improve safety and efficacy by skin targeting.